Professor Anwen Williams
Prosiectau fel Prif Ymchwiliwr
- CD59 - A target to arrest age-related cartilage destruction in osteoarthritis (15.10.2010 - 14.10.2011)
- Death receptor 3: A regulator of bone turnover and new target for therapy for osteoporosis? (01.10.2009 - 01.10.2012)
- Does galectin-3 inhibition resynchronize the aberrant vascular constriction responses associated with inflammatory arthritis (01.10.2017 - 30.09.2018)
- Engineering TCRs for greater specifically by targeting the non-CDR framework regions (01.10.2017 - 30.09.2020)
- Galectin-3 inhibition ablates detrimental vascular pathology associated with inflammatory arthritis (01.02.2017 - 31.08.2017)
Prosiectau fel Cyd-Ymchwiliwr
- Cardiff Institute of Biomechanics and BioEngineering Research (CIBER) (01.10.2009 - 31.03.2015)
- Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre (CREATE Centre) (01.07.2012 - 31.07.2017)
- Defining the efficacy and potency of FE-999301 in experimental inflammatory arthritis (11.03.2013 - 31.05.2014)
- Drug induced stabilisation of RyR2 to improve calcium handling and cardiac function in inherited and acquired cardiac disease (15.09.2015 - 30.09.2020)
- High resolution cabinate x-ray and molecular imaging unit (01.01.2009 - 31.12.2009)